|
Market Cap (18-May) $51,955,920 (1,730th) |
Close (30-Jun) $0.020 |
Volume (30-Jun) 31,196 |
Shortsold (8-May) 1,719,548 (0.86%) (192nd) |
|
52w High $0.053 |
52w Low $0.004 |
P/E - |
EPS 0 |
BXN released this announcement to the ASX on 20 March 2023, 8:30. The announcement is not marked as price sensitive, and is 4 page(s) in length and 236.12kb in size.
You can view all announcements from BXN and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from BXN | |
|---|---|
| Bioxyne Launches BLS Clinics - Online Healthcare | 13 June 2023, 9:05 |
| Becoming a substantial holder | 8 June 2023, 16:36 |
| Becoming a substantial holder | 31 May 2023, 17:30 |
| Bioxyne Executes SPA to Acquire Breathe Life Sciences | 20 March 2023, 8:30 |
| Becoming a substantial holder | 27 February 2023, 11:04 |
| Half Yearly Report and Accounts | 23 February 2023, 16:22 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 27 January 2023, 8:38 |
You must be logged in to post a reply.
Bioxyne 